Navigation Links
Elixir Bio-Tech Inc. Elected One of Top 50 Emerging Companies by 100 Venture Capital Funds & Angel Investors

LAS CRUCES, N.M., Feb. 2, 2011 /PRNewswire/ -- Elixir Bio-Tech Inc. (EBT), a New Mexico Algae Biotech company, has been named one of the top fifty winners of the FundingPost's 7th annual "Pitching Across America™" competition.

EBT is launching its Algae Biomass Feedstock project in Luna County, NM to demonstrate accelerated approaches in producing multi-purpose feedstock with ground-breaking Proprietary and Patent Pending Technology for Open and Closed Algae Biomass Systems. EBT's experienced Algae engineering, production, and marketing team, is establishing strategic partners.

FundingPost (, a company that has been Introducing entrepreneurs to investors for almost 5 years, established the "Pitching Across America, (PAA)" the largest Venture Capital competition ever organized, in which Venture Funds and Investors served as judges voting on 300 business summaries from emerging companies nationwide. PAA was sponsored by WolfBlock ( and PRNewswire (  

Emerging companies were evaluated on a scale of 1 to 10. Judging criteria consisted of key points: the professionalism of the written summary, current stage of development, competitive advantage, need in the marketplace, feasibility for success, and whether the company is "VentureWorthy(TM)."

"We're very pleased to have been chosen for recognition from such an impressive list of companies throughout the U.S.," said Richard Warren, CEO of Elixir Bio-Tech Inc., a "Grass Roots" company: "FundingPost has given us an opportunity to reach an excellent selection of visionary investors. While our customer base continues to grow, in the Algae Nutraceutical markets, the right funding partner(s) can accelerate the establishment of the company's production facility. Our company also plans to benefit from biofuel collaborations with NMSU, Santa Fe College and Sapphire through subcontracting, R&D work study and local employment."

FundingPost Venture Capital judges found Elixir's business summary compelling because it expressed the critical need for advanced biofuel production and phytochemical co-products along with reduced carbon emissions and wastewater treatment that this project addresses.

Companies need to be in compliance, along with adequate financing to take advantage of alternative energy legislation," said Joe Rubin, Director, of FundingPost. "Elixir Bio-Tech Inc. has an exciting innovative rural algae biomass thrust and we know that FundingPost and the 'Pitching Across America' win will benefit them as they seek funding this year."

Press Release Contact: Gregory Edwards, Vice President, Elixir Bio-Tech Inc., Tel: 877-223-6316; Fax: 575-527-4252 or

SOURCE Elixir Bio-Tech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million
2. Bio-Tech Medical Software, Inc. Biometrics Joins Forces with the University of Central Florida to Fight Diversion and Help Combat Prescription Narcotic Drug Abuse
3. Elbit Imaging Evaluating Establishment of a Subsidiary to Hold its Bio-Tech and Medical Investments
4. Weikang Bio-Technology Reports Second Quarter 2010 Financial Results
5. Weikang Bio-Technology to Present at Rodman and Renshaws Annual Global Investment Conference on September 14th 2010
6. Weikang Bio-Technology Issues 2010 and 2011 Fiscal Year Guidance
7. JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States
8. Fujitsu PalmSecure and HT Systems PatientSecure Selected by BayCare Health System to Protect Patient Confidentiality and Prevent Medical Identity Theft
9. NEXCORE Technology Selected to Manufacture New Endoscopic Cryotherapy Device
10. Netsmart Technologies Selected by City and County of San Francisco to Provide Integrated Behavioral Healthcare Software System
11. Douglas Oberhelman Elected to Lilly Board of Directors
Post Your Comments:
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
(Date:6/23/2016)... adds 2016 global ... pharmaceuticals section with historic and forecast data along ... Complete report on the Cell Culture ... companies and supported with 261 tables and figures ... The Global Cell Culture Media Industry ...
Breaking Biology Technology:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):